Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send dochub support via email, link, or fax. You can also download it, export it or print it out.
How to edit Support plus form online
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
With DocHub, making changes to your paperwork takes only a few simple clicks. Make these quick steps to edit the PDF Support plus form online free of charge:
Sign up and log in to your account. Log in to the editor using your credentials or click Create free account to examine the tool’s features.
Add the Support plus form for redacting. Click the New Document option above, then drag and drop the file to the upload area, import it from the cloud, or using a link.
Modify your file. Make any changes needed: add text and photos to your Support plus form, underline details that matter, remove sections of content and substitute them with new ones, and insert symbols, checkmarks, and areas for filling out.
Finish redacting the template. Save the modified document on your device, export it to the cloud, print it right from the editor, or share it with all the parties involved.
Our editor is super intuitive and efficient. Try it now!
If you are uninsured or underinsured, Amgen Safety Net Foundation is a nonprofit patient assistance program sponsored by Amgen that helps qualifying patients access Amgen medicines at no cost. Click here to learn more. With Otezla, you dont have to do it alone.
What company sells Otezla?
THOUSAND OAKS, Calif. , Nov. 21, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to Otezla (apremilast), the only oral, non-biologic treatment for moderate-to-severe plaque psoriasis and psoriatic arthritis.
When does Otezla go off patent?
Appeals Court Affirms Validity of Patent Expiring in 2028 ( Zydus ). Todays decision affirms the permanent injunction entered by the district court prohibiting Sandoz and Zydus from making, using, selling, offering to sell, or importing each of their generic versions of Otezla until February 2028 .
What is Amgen Support Plus?
Bridge to Commercial Coverage Offer: If the patients health plan requires a prior authorization or if patient experiences a delay in obtaining approval for Otezla (apremilast), the patient can receive Otezla free for up to twelve (12) prescription fills within twelve (12) months from the date of the first
What conditions does Otezla treat?
What is this medication? APREMILAST (a PRE mil ast) treats arthritis and psoriasis. It may also be used to treat mouth ulcers in people with a condition that causes blood vessel swelling (Behcet syndrome). It works by decreasing inflammation.
Related Searches
Otezla support plus enrollment formOtezla support plus Fax numberOtezla patient assistance form pdfAmgen support plusOtezla enrollment form pdfOtezla enrollment form 2025Amgen patient assistance formAmgen enrollment form
Related forms
2024 Schedule PA-41 X - Amended PA Fiduciary Income Tax Schedule (PA-41 X)
The recommended twice daily apremilast dose should be taken approximately 12 hours apart (morning and evening), with no food restrictions. If patients miss a dose, the next dose should be taken as soon as possible.
Is there a bridge program for Otezla?
Please ask your Amgen SupportPlus Representative to help you understand eligibility for the Amgen SupportPlus Co-Pay Card by calling (866) 264-2778.
Related links
Patient Financial Assistance Application
Ensure contact information for patient and facility is filled in at the top of the form. Financial Assistance is available to domestic residents of the US.
This site uses cookies to enhance site navigation and personalize your experience.
By using this site you agree to our use of cookies as described in our Privacy Notice.
You can modify your selections by visiting our Cookie and Advertising Notice.... Read more...Read less
